Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-amlodipine in Hypertension
NCT03038451Phase 4Completed
- Sponsor
- Neutec Group
- Start
- Mar 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Levamlodipine in hypertension (HTN), sponsored by Neutec Group. Started Mar 2013; status: completed.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03038451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038451.